| P2093 | author name string | F Y Lee | |
| P2860 | cites work | Some studies of the active intermediates formed in the microsomal metabolism of cyclophosphamide and isophosphamide | Q69733875 |
| | Glutathione and glutathione transferase levels in mouse granulocytes following cyclophosphamide administration | Q69989393 |
| | Altered mouse bone marrow glutathione and glutathione transferase levels in response to cytotoxins | Q70070358 |
| | Comparative in vitro cytotoxicity of cyclophosphamide, its major active metabolites and the new oxazaphosphorine ASTA Z 7557 (INN mafosfamide) | Q70589430 |
| | Role of aldehyde dehydrogenase in cyclophosphamide-resistant L1210 leukemia | Q70641051 |
| | Does acrolein contribute to the cytotoxicity of cyclophosphamide? | Q70730277 |
| | Role of glutathione in the metabolism-dependent toxicity and chemotherapy of cyclophosphamide | Q70866970 |
| | Cytotoxicity and DNA cross-linking activity of 4-sulfidocyclophosphamides in mouse leukemia cells in vitro | Q71507575 |
| | Factors influencing the quantitative estimation of the in vivo survival of cells from solid tumors | Q72296540 |
| | Cell subpopulations dispersed from solid tumours and separated by centrifugal elutriation | Q36045196 |
| | NMR spectroscopic studies of intermediary metabolites of cyclophosphamide. A comprehensive kinetic analysis of the interconversion of cis- and trans-4-hydroxycyclophosphamide with aldophosphamide and the concomitant partitioning of aldophosphamide b | Q38581308 |
| | Redox properties and rate constants in free-radical mediated damage | Q39668593 |
| | The roles of intracellular glutathione in antineoplastic chemotherapy | Q39743733 |
| | Glutathione metabolism as a determinant of therapeutic efficacy: a review | Q40184201 |
| | Effect of glutathione depletion by L-buthionine sulfoximine on the cytotoxicity of cyclophosphamide in single and fractionated doses to EMT6/SF mouse tumors and bone marrow. | Q46151273 |
| | Heterogeneity of glutathione content in human ovarian cancer. | Q54343380 |
| | Isolation and mass spectral identification of blood metabolities of cyclophosphamide: Evidence for phosphoramide mustard as the biologically active metabolite | Q66931110 |
| | An experimental and analytical study of oxygen depletion in stirred cell suspensions | Q67260659 |
| | Comparative pharmacologic study in vitro and in vivo with cyclophosphamide (NSC-26271), cyclophosphamide metabolites, and plain nitrogen mustard compounds | Q67796446 |
| | The problem of oncostatic specificity of cyclophosphamide (NSC-26271): Studies on reactions that control the alkylating and cytotoxic activity | Q67796451 |
| | Glutathione as a determinant of cellular response to doxorubicin | Q68297845 |
| | Glutathione depletion as a determinant of sensitivity of human leukemia cells to cyclophosphamide | Q68737138 |
| | A proposed mechanism of resistance to cyclophosphamide and phosphoramide mustard in a Yoshida cell line in vitro | Q69588122 |
| | Inhibition of the protective effect of cyclophosphamide by pre-treatment with buthionine sulfoximine | Q69592507 |
| | Effect of thiol manipulation on chemopotentiation by nitroimidazoles | Q69600034 |
| | Activation mechanisms of mafosfamide and the role of thiols in cyclophosphamide metabolism | Q69729345 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 45-50 | |
| P577 | publication date | 1991-01-01 | |
| P1433 | published in | British Journal of Cancer | Q326309 |
| P1476 | title | Glutathione diminishes the anti-tumour activity of 4-hydroperoxycyclophosphamide by stabilising its spontaneous breakdown to alkylating metabolites | |
| P478 | volume | 63 | |